Neoadjuvant Treatment of Colon Cancer

NCT01108107 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

76

Enrollment

OTHER

Sponsor class

Conditions

Colon Cancer

Interventions

DRUG: Oxaliplatin
DRUG: Capecitabine
DRUG: Oxaliplatin
DRUG: Capecitabine
BIOLOGICAL: Panitumumab

Sponsor

Vejle Hospital

Collaborators

[object Object]